Robert Wood Johnson Medical School Header image Child Health Institute of New Jersey

Leadership

The Cardiovascular Institute of New Jersey is overseen by a Board of Directors, consisting of prominent members of the New Jersey medical, corporate, and philanthropic community:

  • Robert E. Campbell.  Chairman; Past Chairman, The Robert Wood Johnson Foundation
  • Peter S. Amenta, M.D., Ph.D. Professor and Interim Dean, UMDNJ-Robert Wood Johnson Medical School
  • Wendy L. Dixon, Ph.D. President, Global Marketing and CMO, Bristol Myers Squibb
  • John J. Gantner. Chief Financial Officer, Robert Wood Johnson University Hospital
  • John J. Heldrich, Sr. Executive Committee Member, Johnson and Johnson (Retired)
  • Harvey A. Holzberg. President, Robert Wood Johnson Health System
  • John Kostis, M.D. Professor & Chairman, Department of Medicine, UMDNJ-Robert Wood Johnson Medical School; Founding Director, Cardiovascular Institute of New Jersey
  • Hubert G. Pouleur, M.D., Ph.D. Senior Medical Director, Cardiovascular Group, Pfizer Pharmaceuticals
  • Sol I. Rajfer, M.D. Senior Vice President, Global Product Realization, Sanofi-Aventis
  • Norman Reitman, M.D. Prominent cardiologist (Retired)
  • Enrico P. Veltri, M.D. Group Vice President, Worldwide Clinical Development, Schering-Plough Research Institute
  • Ralph Voorhees